The session will provide an overview of the current knowledge on low-dose effects on human health, followed by presentations on screening (breast and lung) to clarify the radiogenic risk in this context and on patient perspectives. A panel discussion will focus on technological advances' impact on the current dose levels.
Chairpersons' introduction
Guy Frija, Paris / France
Reinhard W.R. Loose, Nuremberg / Germany
Technology advances and artificial intelligence (AI) promises for lowering the CT dose exposure
Mahadevappa Mahesh, Baltimore / United States
An overview of the concept of low doses: is there a need for an update?
Virginia Tsapaki, Vienna / Austria
Are recurrent exposures changing the game?
Donald P. Frush, Durham / United States
Epidemiological studies on low doses: are biases and limits handled in the recent studies on paediatric CT studies?
Marie-Odile Bernier, Fontenay Aux Roses / France
Panel discussion: Is the risk perception related to technology advances, epidemiological studies or to anything else?